News

Blockonomi1d
Two Seas Capital Moves to Block $9B CoreWeave Deal Over Low Valuation
Two Seas Capital moves to block CoreWeave’s $9B all-stock deal for Core Scientific, citing low valuation and high risk.
Activist Two Seas Capital to oppose Core Scientific’s sale to CoreWeave
Two Seas Capital LP, the largest active shareholder of Core Scientific, Inc., announced Thursday its opposition to the ...
Two Seas Capital, Core Scientific's Largest Active Shareholder, Announces Intention to Vote Against the Proposed Sale to CoreWeave
Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and the largest active shareholder of ...
Two Seas Capital Opposes Core Scientific–CoreWeave Merger, Calls Deal Undervalued, Risky For Shareholders
Two Seas Capital opposes Core Scientific's all-stock acquisition by CoreWeave, citing undervaluation and risk.